Michael E. Kuligowski

1.1k total citations · 1 hit paper
43 papers, 791 citations indexed

About

Michael E. Kuligowski is a scholar working on Dermatology, Immunology and Allergy and Rheumatology. According to data from OpenAlex, Michael E. Kuligowski has authored 43 papers receiving a total of 791 indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Dermatology, 31 papers in Immunology and Allergy and 10 papers in Rheumatology. Recurrent topics in Michael E. Kuligowski's work include Dermatology and Skin Diseases (36 papers), Allergic Rhinitis and Sensitization (20 papers) and Food Allergy and Anaphylaxis Research (11 papers). Michael E. Kuligowski is often cited by papers focused on Dermatology and Skin Diseases (36 papers), Allergic Rhinitis and Sensitization (20 papers) and Food Allergy and Anaphylaxis Research (11 papers). Michael E. Kuligowski collaborates with scholars based in United States, Canada and Poland. Michael E. Kuligowski's co-authors include Kim Papp, Kang Sun, May E. Venturanza, Brian Kim, Adnan Nasir, Eric L. Simpson, Jacek C. Szepietowski, Leon Kircik, Michael Howell and Lawrence F. Eichenfield and has published in prestigious journals such as Journal of Allergy and Clinical Immunology, Journal of Investigative Dermatology and Journal of the American Academy of Dermatology.

In The Last Decade

Michael E. Kuligowski

42 papers receiving 769 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efficacy and safety of ruxolitinib cream for the treatment of atopic dermatitis: Results from 2 phase 3, randomized, double-blind studies

2021 199 citations Kim Papp, Jacek C. Szepietowski et al. Journal of the American Academy of Dermatology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael E. Kuligowski United States	11	635	459	186	150	134	43	791
Hanne Norsgaard Denmark	14	392 0.6×	116 0.3×	53 0.3×	420 2.8×	133 1.0×	23	661
Ruhong Cheng China	13	151 0.2×	78 0.2×	42 0.2×	90 0.6×	49 0.4×	42	521
Fiona Kuo United States	5	245 0.4×	78 0.2×	58 0.3×	180 1.2×	28 0.2×	10	517
B. Stott United Kingdom	8	106 0.2×	67 0.1×	167 0.9×	144 1.0×	88 0.7×	13	461
Simone Rubant Germany	11	126 0.2×	39 0.1×	25 0.1×	222 1.5×	56 0.4×	21	520
Agatha Schwarz Germany	6	246 0.4×	45 0.1×	22 0.1×	234 1.6×	30 0.2×	7	473
Seiji Kondo Canada	7	245 0.4×	50 0.1×	28 0.2×	183 1.2×	34 0.3×	9	472
Grace W. Kimmel United States	9	202 0.3×	32 0.1×	37 0.2×	124 0.8×	38 0.3×	15	349
Gaelle Poyet France	5	232 0.4×	98 0.2×	23 0.1×	489 3.3×	50 0.4×	6	700
Johanna Kotrba Germany	9	56 0.1×	81 0.2×	50 0.3×	236 1.6×	78 0.6×	13	414

Countries citing papers authored by Michael E. Kuligowski

Since Specialization

Citations

This map shows the geographic impact of Michael E. Kuligowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael E. Kuligowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael E. Kuligowski more than expected).

Fields of papers citing papers by Michael E. Kuligowski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael E. Kuligowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael E. Kuligowski. The network helps show where Michael E. Kuligowski may publish in the future.

Co-authorship network of co-authors of Michael E. Kuligowski

This figure shows the co-authorship network connecting the top 25 collaborators of Michael E. Kuligowski. A scholar is included among the top collaborators of Michael E. Kuligowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael E. Kuligowski. Michael E. Kuligowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Eichenfield, Lawrence F., Eric L. Simpson, Kim Papp, et al.. (2024). Efficacy, Safety, and Long-Term Disease Control of Ruxolitinib Cream Among Adolescents with Atopic Dermatitis: Pooled Results from Two Randomized Phase 3 Studies. American Journal of Clinical Dermatology. 25(4). 669–683. 8 indexed citations

Bissonnette, Robert, Lawrence F. Eichenfield, Eric L. Simpson, et al.. (2023). Estimands for atopic dermatitis clinical trials: Expert opinion on the importance of intercurrent events. Journal of the European Academy of Dermatology and Venereology. 37(5). 976–983. 3 indexed citations

Blauvelt, Andrew, Leon Kircik, Kim Papp, et al.. (2022). Rapid pruritus reduction with ruxolitinib cream treatment in patients with atopic dermatitis. Journal of the European Academy of Dermatology and Venereology. 37(1). 137–146. 15 indexed citations

Leung, Donald Y.M., Amy S. Paller, Andrea L. Zaenglein, et al.. (2022). Safety, pharmacokinetics, and efficacy of ruxolitinib cream in children and adolescents with atopic dermatitis. Annals of Allergy Asthma & Immunology. 130(4). 500–507.e3. 13 indexed citations

Blauvelt, Andrew, Jacek C. Szepietowski, Kim Papp, et al.. (2022). Itch-free state in patients with atopic dermatitis treated with ruxolitinib cream: A pooled analysis from two randomized phase 3 studies. Journal of the American Academy of Dermatology. 88(3). 651–653. 9 indexed citations

Papp, Kim, Jacek C. Szepietowski, Leon Kircik, et al.. (2022). Long-term safety and disease control with ruxolitinib cream in atopic dermatitis: Results from two phase 3 studies. Journal of the American Academy of Dermatology. 88(5). 1008–1016. 58 indexed citations

Blauvelt, Andrew, Jacek C. Szepietowski, Kim Papp, et al.. (2021). 325 Ruxolitinib cream rapidly decreases skin pain in atopic dermatitis. Journal of Investigative Dermatology. 141(5). S57–S57. 2 indexed citations

Gong, Xiaohua, Xuejun Chen, Michael E. Kuligowski, et al.. (2021). Pharmacokinetics of Ruxolitinib in Patients with Atopic Dermatitis Treated With Ruxolitinib Cream: Data from Phase II and III Studies. American Journal of Clinical Dermatology. 22(4). 555–566. 52 indexed citations

Papp, Kim, Jacek C. Szepietowski, Leon Kircik, et al.. (2021). Efficacy and Safety of Ruxolitinib Cream for the Treatment of Atopic Dermatitis: Pooled Analysis of Two Phase 3, Randomized, Double-Blind Studies. SKIN The Journal of Cutaneous Medicine. 5(1). s8–s8. 1 indexed citations

10.

Simpson, Eric L., Robert Bissonnette, Michael E. Kuligowski, et al.. (2021). 311 Effects of ruxolitinib cream in patients with atopic dermatitis with head and/or neck involvement. Journal of Investigative Dermatology. 141(5). S55–S55. 2 indexed citations

11.

Simpson, Eric L., et al.. (2021). 329 Efficacy of ruxolitinib cream in adults and adolescents with atopic comorbidities. Journal of Investigative Dermatology. 141(5). S58–S58. 2 indexed citations

12.

Blauvelt, Andrew, Jacek C. Szepietowski, Kim Papp, et al.. (2021). 26884 Ruxolitinib cream rapidly decreases pruritus in atopic dermatitis: Pooled results from two phase 3 studies. Journal of the American Academy of Dermatology. 85(3). AB121–AB121. 9 indexed citations

13.

Papp, Kim, Jacek C. Szepietowski, Leon Kircik, et al.. (2021). Efficacy and safety of ruxolitinib cream for the treatment of atopic dermatitis: Results from 2 phase 3, randomized, double-blind studies. Journal of the American Academy of Dermatology. 85(4). 863–872. 199 indexed citations breakdown →

14.

Kim, Brian, Kang Sun, Kim Papp, et al.. (2020). Effects of ruxolitinib cream on pruritus and quality of life in atopic dermatitis: Results from a phase 2, randomized, dose-ranging, vehicle- and active-controlled study. Journal of the American Academy of Dermatology. 82(6). 1305–1313. 81 indexed citations

15.

Owens, Sherry, et al.. (2019). 998 Ruxolitinib cream significantly modulates inflammatory profiles of atopic dermatitis patients. Journal of Investigative Dermatology. 139(5). S173–S173. 4 indexed citations

16.

Kuligowski, Michael E., et al.. (2016). 543 An evaluator blinded study to evaluate the cumulative irritation potential of topically-applied GSK2894512 cream in healthy subjects. Journal of Investigative Dermatology. 136(5). S96–S96. 1 indexed citations

17.

Kuligowski, Michael E., et al.. (1992). Allergic contact hand dermatitis from hydrangea: report of a 10th case. Contact Dermatitis. 26(4). 269–270. 3 indexed citations

18.

Gliński, Wiesław, et al.. (1991). Ultrastructural changes of the skin induced by human leukocyte elastase and cathepsin G.. Acta Dermato Venereologica. 71(4). 277–282. 4 indexed citations

19.

Kuligowski, Michael E., et al.. (1991). Multiple fixed drug eruption due to ibuprofen. Contact Dermatitis. 25(4). 259–260. 8 indexed citations

20.

Kuligowski, Michael E., et al.. (1989). Apoptosis in Bowenʼs Disease; An Ultrastructural Study. American Journal of Dermatopathology. 11(1). 13–21. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact